AstraZeneca studies another possible case of neurological disease in an Oxford vaccine volunteer

• Salud.AstraZeneca suspends trials of Oxford vaccine due to "serious adverse reaction" of a volunteer

AstraZeneca

, the Swedish-British pharmaceutical company that in collaboration with the University of

working on the development of a vaccine against Covid-19, has suffered a new setback in its career to obtain it.

Days after reporting that one of its volunteers had developed a "serious adverse reaction", which later became known to be

, the 'New York Times' reports that another of the people participating in the trial has also developed a problem neurological.

The newspaper cites sources close to the development of the vaccine who assure that this second patient would also suffer from transverse myelitis.

The vaccine expert from the Oregon Health and Sciences University (USA),

, has warned that "if there are two cases" of the same disease "there begins to be a dangerous pattern."

AstraZeneca assures that it is "unlikely" that these diseases are associated and that "there is no evidence" to state "with certainty" that its vaccine can cause them.

Transverse myelitis is a neurological disorder that causes inflammation of the spinal cord.

This condition damages the myelin, the insulating material that covers the fibers of nerve cells.

This injury disrupts the nervous system by disrupting communication between the nerves in the spinal cord with the rest of the body.

According to the criteria of The Trust Project

Know more

See links of interest

• News

• Coronavirus Madrid

• Translator

• Programming

• Horoscope

• Films

• Topics

• Quarterfinals of the Rome Masters, live: Rafael Nadal - Diego Schwartzman

• Herbalife Gran Canaria - RETAbet Bilbao Basket

• Acunsa Gipuzkoa Basket - Real Madrid

• Celta de Vigo - Valencia CF

• Arsenal - West Ham United